U.S. markets close in 4 hours 10 minutes
  • S&P 500

    4,173.44
    +0.02 (+0.00%)
     
  • Dow 30

    34,081.53
    -55.78 (-0.16%)
     
  • Nasdaq

    13,986.23
    +36.01 (+0.26%)
     
  • Russell 2000

    2,259.90
    +20.27 (+0.91%)
     
  • Crude Oil

    61.54
    +0.19 (+0.31%)
     
  • Gold

    1,781.10
    -12.00 (-0.67%)
     
  • Silver

    26.20
    -0.36 (-1.37%)
     
  • EUR/USD

    1.2025
    -0.0014 (-0.12%)
     
  • 10-Yr Bond

    1.5790
    +0.0150 (+0.96%)
     
  • GBP/USD

    1.3851
    -0.0081 (-0.58%)
     
  • USD/JPY

    108.1200
    +0.0770 (+0.07%)
     
  • BTC-USD

    54,466.13
    -1,688.69 (-3.01%)
     
  • CMC Crypto 200

    1,276.08
    +33.02 (+2.66%)
     
  • FTSE 100

    6,938.24
    +42.95 (+0.62%)
     
  • Nikkei 225

    29,188.17
    +679.62 (+2.38%)
     

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of UROV, SNSS, TCF, and PS Mergers

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Rigrodsky & Long, P.A.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

WILMINGTON, Del., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

Urovant Sciences Ltd. (NASDAQ GS: UROV) regarding possible breaches of fiduciary duties and other violations of law related to Urovant’s agreement to be acquired by Sumitovant Biopharma Ltd. Under the terms of the agreement Urovant’s shareholders will receive $16.25 per share in cash. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-urovant-sciences-ltd.

Sunesis Pharmaceuticals, Inc. (NASDAQ CM: SNSS) regarding possible breaches of fiduciary duties and other violations of law related to Sunesis’ agreement to merge with Viracta. Under the terms of the agreement, Sunesis will issue a number of shares of Sunesis common stock to shareholders of Viracta. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-sunesis-pharmaceuticals-inc.

TCF Financial Corporation (NASDAQ GS: TCF) regarding possible breaches of fiduciary duties and other violations of law related to TCF Financial’s agreement to be acquired by Huntington Bancshares Incorporated. Under the terms of the agreement, TCF Financial’s shareholders will receive 3.0028 shares of Huntington Bancshares per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-tcf-financial-corporation-merger.

Pluralsight, Inc. (NASDAQ GS: PS) regarding possible breaches of fiduciary duties and other violations of law related to Pluralsight’s agreement to be acquired by affiliates of Vista Equity Partners VII, L.P. Under the terms of the agreement, Pluralsight’s shareholders will receive $20.26 in cash per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-pluralsight-inc-merger.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
https://rl-legal.com